<DOC>
	<DOC>NCT02561468</DOC>
	<brief_summary>Nefopam is administered as a preemptive analgesic drug to the patient undergoing breast cancer surgery. It will be evaluated whether postoperative acute and chronic pain can be reduced.</brief_summary>
	<brief_title>The Preemptive Analgesic Efficacy of Nefopam</brief_title>
	<detailed_description />
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Nefopam</mesh_term>
	<criteria>Patients diagnosed with breast cancer Lumpectomy with axillary lymph node dissection or Lumpectomy with sentinel lymph node biopsy American Society of Anesthesiologists physical status I or II Refusal Seizure Cardiac disease Monoamine oxidase inhibitor user Urologic disease Glucoma Preoperative analgesic drug medication Pregnancy Recurred breast cancer patient</criteria>
	<gender>Female</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>April 2016</verification_date>
</DOC>